A case report of progressive multifocal leukoencephalopathy during steroid treatment for ANCA-associated renal vasculitis. 2020

Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
Division of Clinical Medicine, Department of Nephrology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.

an 80-year-old woman presented with rapidly progressive glomerulonephritis and was admitted to our hospital. Myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA) was positive. We diagnosed ANCA-associated renal vasculitis (ANCA-RV). Treatment was initiated with intravenous methylprednisolone pulse therapy, followed by prednisolone (PSL) at 30 mg/day. We gradually reduced the PSL dose to 7.5 mg/day over 6 months. At that time, the patient developed disturbances of consciousness which progressed subacutely. MRI revealed regions of patchy white matter with an increased signal on T2-weighted, fluid attenuated inversion recovery (FLAIR) sequences and diffusion-weighted sequences. JC virus DNA was detected in the cerebrospinal fluid (CSF) by polymerase chain reaction (PCR), leading to a diagnosis of progressive multifocal leukoencephalopathy (PML). PML is a rare infectious demyelinating disease of the central nervous system caused by JC virus infection, occurring in highly immunosuppressed individuals such as HIV-infected patients and patients using some biological agents, and having a very poor prognosis. In the present case, PML may have been associated with steroid use, although there are very few case reports of PML in patients taking only steroids. We report progressive multifocal leukoencephalopathy during steroid treatment of ANCA-RV. When patients show progressive disturbance of consciousness during treatment for ANCA-RV, we need to take PML into consideration for differential diagnosis.

UI MeSH Term Description Entries
D007577 JC Virus A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient's initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus. Human Polyomavirus JC,JC polyomavirus,Polyomavirus, JC,John Cunningham Virus,Polyomavirus hominis 2,Polyomavirus JC, Human,Virus, John Cunningham
D007968 Leukoencephalopathy, Progressive Multifocal An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7) Encephalitis, JC Polyomavirus,Progressive Multifocal Leukoencephalopathy,JC Polyomavirus Encephalopathy,Encephalopathies, JC Polyomavirus,Encephalopathy, JC Polyomavirus,JC Polyomavirus Encephalitis,Leukoencephalopathies, Progressive Multifocal,Multifocal Leukoencephalopathies, Progressive,Multifocal Leukoencephalopathy, Progressive,Progressive Multifocal Leukoencephalopathies
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity

Related Publications

Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
October 1996, Italian journal of neurological sciences,
Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
June 1962, Neurology,
Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
March 2021, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
January 1971, Neurology,
Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
January 2005, Functional neurology,
Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
June 2023, Cureus,
Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
April 2023, Acta medica Indonesiana,
Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
January 1999, WMJ : official publication of the State Medical Society of Wisconsin,
Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
December 2022, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
Takashi Tawara, and Hirayasu Kai, and Mikiko Kageyama, and Tomoki Akiyama, and Takahiro Matsunaga, and Aki Sakuma, and Ryota Ishii, and Ryouya Tsunoda, and Tetusya Kawamura, and Akiko Fujita, and Shuzo Kaneko, and Naoki Morito, and Chie Saito, and Joichi Usui, and Kunihiro Yamagata
January 2024, Journal of neurosciences in rural practice,
Copied contents to your clipboard!